Montai Health Competitors and Similar CompaniesClear all
Montai Health's competitors and similar companies include Compugen, Bioxytran, Specific Diagnostics and Metabolomic Technologies.
 Montai Health Montai Health is a company that develops an AI small molecule platform for the treatment of chronic diseases. |  Bioxytran Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies. |  Metabolomic Technologies Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
| |||
Founding Date | Founding Date 2022 | Founding Date 1993 | Founding Date 2008 | Founding Date 2011 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Holon, IL HQ South San Francisco, US | Locations Newton, US HQ Newton, US | Locations San Jose, US HQ | Locations Edmonton, CA HQ Edmonton, CA |
Employees | Employees 681% increase | Employees 74 | Employees 3 | Employees 75 | Employees 3 |
Financial | |||||
Net income | Net income N/A | Net income $35.3m (FY, 2025) | Net income ($2.1m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 12.5m | Total funding raised $ 4.2m |
For sources of this data, please see the company profile
View Company Profiles
Bioxytran
HQ
Newton, US
Employees
3
Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies.
View company
Specific Diagnostics
HQ
San Jose, US
Specific Diagnostics is a company that develops in vitro diagnostic systems.
View companyMetabolomic Technologies
HQ
Edmonton, CA
Employees
3
Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
View company